Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y
Authors
Keywords
-
Journal
BMJ Open
Volume 6, Issue 4, Pages e010422
Publisher
BMJ
Online
2016-04-09
DOI
10.1136/bmjopen-2015-010422
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A family with various symptomatology suggestive of Anderson–Fabry disease and a genetic polymorphism of alpha galactosidase A gene
- (2015) Antonino Tuttolomondo et al. CLINICAL BIOCHEMISTRY
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2015) Roberto M. Lang et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Thromboembolic events in Fabry disease and the impact of factor V Leiden
- (2015) M. Lenders et al. NEUROLOGY
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2015) Roberto M. Lang et al. European Heart Journal-Cardiovascular Imaging
- Gene Mutations Versus Clinically Relevant Phenotypes: Lyso-Gb3 Defines Fabry Disease
- (2014) M. Niemann et al. Circulation-Cardiovascular Genetics
- The Fabry Cardiomyopathy - Diagnostic Approach and Current Treatment
- (2014) Frank Weidemann et al. CURRENT PHARMACEUTICAL DESIGN
- Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A-10T genotype
- (2014) Michael Schelleckes et al. Orphanet Journal of Rare Diseases
- Characterization of Pain in Fabry Disease
- (2013) Nurcan Üçeyler et al. CLINICAL JOURNAL OF PAIN
- Anderson-Fabry Disease: A Multiorgan Disease
- (2013) Antonino Tuttolomondo et al. CURRENT PHARMACEUTICAL DESIGN
- Neurological Complications of Anderson-Fabry Disease
- (2013) Antonino Tuttolomondo et al. CURRENT PHARMACEUTICAL DESIGN
- Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease
- (2013) Johannes Krämer et al. EUROPEAN HEART JOURNAL
- Fabry patients' experiences with the timing of diagnosis relevant for the discussion on newborn screening
- (2013) Machtelt G. Bouwman et al. MOLECULAR GENETICS AND METABOLISM
- Multifocal White Matter Lesions Associated with the D313Y Mutation of the α-Galactosidase A Gene
- (2013) Malte Lenders et al. PLoS One
- Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: Findings from the Fabry Registry
- (2010) Torquil Watt et al. GENETICS IN MEDICINE
- Plasma globotriaosylsphingosine as a biomarker of Fabry disease
- (2010) Tadayasu Togawa et al. MOLECULAR GENETICS AND METABOLISM
- Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy
- (2010) N. Uceyler et al. NEUROLOGY
- Fabry disease
- (2010) Dominique P Germain Orphanet Journal of Rare Diseases
- Reference data for quantitative sensory testing (QST): Refined stratification for age and a novel method for statistical comparison of group data
- (2010) Walter Magerl et al. PAIN
- High Incidence of the Cardiac Variant of Fabry Disease Revealed by Newborn Screening in the Taiwan Chinese Population
- (2009) Hsiang-Yu Lin et al. Circulation-Cardiovascular Genetics
- Temporal Trends in Health-Related Quality of Life among Hemodialysis Patients in the United States
- (2009) E. Gabbay et al. Clinical Journal of the American Society of Nephrology
- Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onsetGLAmutation c.936+919G>A (IVS4+919G>A)
- (2009) Wuh-Liang Hwu et al. HUMAN MUTATION
- Proposed high-risk screening protocol for Fabry disease in patients with renal and vascular disease
- (2009) C. Auray-Blais et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey
- (2009) A Mehta et al. JOURNAL OF MEDICAL GENETICS
- Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy
- (2009) R. Schiffmann et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Progression of Left Ventricular Functional Abnormalities in Hypertensive Patients with Heart Failure: An Ultrasonic Two-Dimensional Speckle Tracking Study
- (2008) Wojciech Kosmala et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Elevated globotriaosylsphingosine is a hallmark of Fabry disease
- (2008) J. M. Aerts et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Screening for Fabry Disease in Patients with Chronic Kidney Disease: Limitations of Plasma -Galactosidase Assay as a Screening Test
- (2007) J. Andrade et al. Clinical Journal of the American Society of Nephrology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More